Tradestie Institutional Equity Comparison Engine
STTK vs ATYR โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ATYR Overall Edge
ATYR Captures Institutional Edge (2โ0 Pillars ยท 2โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to aTyr Pharma, Inc. Common Stock (ATYR) driven by superior Momentum & Technical, Options & Structure. Fundamentally, STTK trades at N/M Forward P/E with 0.0% operating margin (-66.6% YoY revenue) versus ATYR at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, STTK sits in BREAKDOWN (10th %ile IV; Dealer Gamma Walls on Pro) against ATYR sits in UNCLASSIFIED (36th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
STTK N/M vs ATYR N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin 0.0% vs 0.0% ยท YoY -66.6% vs +0.0%
Momentum & Technical Winner
ATYR
1Y +142.3% vs +541.4% ยท 52W Pos 43% vs 60%
Options & Structure Winner
ATYR
BREAKDOWN (10th %ile IV) vs UNCLASSIFIED (36th %ile IV)
STTK
NASDAQ
Shattuck Labs, Inc. Common Stock
Pharmaceutical Preparations
$4.55
-2.25% 1D
Market Cap
$473.6M
1M Return
-15.18%
1Y Return
+142.29%
Forward P/E
N/M
Unified AI Score
52.1 / 100
HOLD
Tech 57.0
Fund 57.0
Flow 63.0
Mom 60.0
ATYR
NASDAQ
aTyr Pharma, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$4.83
-7.82% 1D
Market Cap
$15.6M
1M Return
+2713.05%
1Y Return
+541.43%
Forward P/E
N/M
Unified AI Score
34.3 / 100
SELL
Tech 50.0
Fund 36.0
Flow 69.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
STTK +142.29%
ATYR +541.43%
Spread: +399.14 pp (ATYR Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | STTK Revenue | ATYR Revenue | STTK Op. Margin | ATYR Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $10M | $0M | -253.5% | -5445.0% | STTK |
| FY2020 | $10M | $10M | -371.8% | -152.2% | ATYR |
| FY2021 | $30M | N/A | -150.8% | N/A | STTK |
| FY2022 | $0M | $10M | -15848.0% | -446.8% | ATYR |
| FY2023 | $0M | $0M | -5549.6% | -15557.8% | STTK |
| FY2024 | $10M | $0M | -1408.3% | -28899.6% | STTK |
| FY2025 | $0M | $0M | -5150.8% | -40856.3% | STTK |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | STTK | ATYR | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $473.6M | $15.6M | Larger Scale | STTK |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -66.6% | +0.0% | Higher Growth | ATYR |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -47.2% | -93.7% | Higher ROE | STTK |
| 52-Week Range Position Momentum | 43% ($2โ$8) | 60% ($0โ$8) | Stronger Trend | ATYR |
| Beta / 30D Volatility Risk Regime | 1.46ฮฒ ยท 76% Vol | -9.57ฮฒ ยท 13806% Vol | Lower Realized Risk | STTK |
| Unified Institutional Score Composite Signal | 52.1 / 100 (HOLD) | 34.3 / 100 (SELL) | Higher Composite | STTK |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full STTK vs ATYR Buy Guide
STTK
BREAKDOWN
59d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
10th %ile
IV Regime
Compressed (<25th %ile)
ATYR
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
36th %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither STTK nor ATYR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.